138 related articles for article (PubMed ID: 7653442)
1. Effects of nicorandil on kinetics of oxygen uptake at the onset of exercise in patients with coronary artery disease.
Koike A; Hiroe M; Yajima T; Adachi H; Shimizu N; Kano H; Sugimoto K; Miyahara Y; Korenaga M; Marumo F
Am J Cardiol; 1995 Sep; 76(7):449-52. PubMed ID: 7653442
[TBL] [Abstract][Full Text] [Related]
2. Effects of isosorbide dinitrate on oxygen uptake kinetics in cardiac patients.
Koike A; Yajima T; Koyama Y; Shimizu N; Kano H; Kobayashi K; Taniguchi K; Marumo F; Hiroe M
Med Sci Sports Exerc; 1998 Feb; 30(2):190-4. PubMed ID: 9502344
[TBL] [Abstract][Full Text] [Related]
3. Effects of nicorandil on exercise tolerance in patients with stable effort angina: a double-blind study.
Hayata N; Araki H; Nakamura M
Am Heart J; 1986 Dec; 112(6):1245-50. PubMed ID: 2947447
[TBL] [Abstract][Full Text] [Related]
4. A double-blind comparison of a beta-blocker and a potassium channel opener in exercise induced angina.
Raftery EB; Lahiri A; Hughes LO; Rose EL
Eur Heart J; 1993 Jul; 14 Suppl B():35-9. PubMed ID: 8370371
[TBL] [Abstract][Full Text] [Related]
5. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients.
Döring G
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S74-81. PubMed ID: 1282180
[TBL] [Abstract][Full Text] [Related]
6. [Effects of nicorandil on coronary collateral circulation depend on the donor arteries].
Umezawa S; Ogawara S; Okamoto Y; Igawa M; Aonuma K; Inada M; Korenaga M; Hiroe M; Marumo F
J Cardiol; 1996 Nov; 28(5):257-66. PubMed ID: 8953399
[TBL] [Abstract][Full Text] [Related]
7. Effects of short-term treatment of nicorandil on exercise-induced myocardial ischemia and abnormal cardiac autonomic activity in microvascular angina.
Chen JW; Lee WL; Hsu NW; Lin SJ; Ting CT; Wang SP; Chang MS
Am J Cardiol; 1997 Jul; 80(1):32-8. PubMed ID: 9205016
[TBL] [Abstract][Full Text] [Related]
8. Effects of nicorandil on left ventricular hemodynamics and volume at rest and during exercise-induced angina pectoris.
Silke B; Verma SP; Ali MS; Goldhammer E; Taylor SH
Am J Cardiol; 1989 Jun; 63(21):49J-55J. PubMed ID: 2525326
[TBL] [Abstract][Full Text] [Related]
9. A double-blind comparison of the long-term efficacy of a potassium channel opener and a calcium antagonist in stable angina pectoris.
Guermonprez JL; Blin P; Peterlongo F
Eur Heart J; 1993 Jul; 14 Suppl B():30-4. PubMed ID: 8370370
[TBL] [Abstract][Full Text] [Related]
10. A potassium channel opener as monotherapy in chronic stable angina pectoris: comparison with placebo.
Why HJ; Richardson PJ
Eur Heart J; 1993 Jul; 14 Suppl B():25-9. PubMed ID: 8370369
[TBL] [Abstract][Full Text] [Related]
11. Exercise capacity after single and twice-daily doses of nicorandil in chronic stable angina pectoris.
Meany TB; Richardson P; Camm AJ; Coltart J; Griffith M; Maltz MB; Signy M
Am J Cardiol; 1989 Jun; 63(21):66J-70J. PubMed ID: 2525329
[TBL] [Abstract][Full Text] [Related]
12. A controlled single-dose study of the efficacy, dose response and duration of action of nicorandil in angina pectoris.
Camm AJ; Maltz MB
Am J Cardiol; 1989 Jun; 63(21):61J-65J. PubMed ID: 2525328
[TBL] [Abstract][Full Text] [Related]
13. Chronic effects of nicorandil on exercise tolerance in patients with stable effort angina pectoris.
Hiasa Y; Hamai K; Wada T; Aihara T; Bando M; Nakai Y; Kataoka Y
Tokushima J Exp Med; 1989 Dec; 36(3-4):65-70. PubMed ID: 2534651
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the efficacy of nicorandil in patients with ischemic heart disease by exercise Tl-201 myocardial SPECT.
Yamazaki J; Iida M; Igarashi M; Hosoi H; Ishiguro S; Hou M; Morishita T; Nakano H; Yabe Y; Koyama N
Int J Clin Pharmacol Ther; 1994 Apr; 32(4):183-91. PubMed ID: 8032578
[TBL] [Abstract][Full Text] [Related]
15. Comparison of nicorandil and atenolol in stable angina pectoris.
Hughes LO; Rose EL; Lahiri A; Raftery EB
Am J Cardiol; 1990 Sep; 66(7):679-82. PubMed ID: 2144705
[TBL] [Abstract][Full Text] [Related]
16. Effects of a new vasodilator, nicorandil, on exercise-induced impairment of left ventricular function in patients with old myocardial infarction.
Yokota M; Horisawa T; Iwase M; Miyahara T; Yoshida J; Kamihara S; Noda S; Tsunekawa A; Koide M; Tsuzuki M
J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S116-22. PubMed ID: 2447418
[TBL] [Abstract][Full Text] [Related]
17. Comparison of antianginal activity of nicorandil, propranolol and diltiazem with reference to the antianginal mechanism.
Kinoshita M; Hashimoto K; Ohbayashi Y; Inoue T; Taguchi H; Mitsunami K
Am J Cardiol; 1989 Jun; 63(21):71J-74J. PubMed ID: 2525330
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of nicorandil (SG-75), a new long-acting drug with nitroglycerin effects, in patients with coronary artery disease: improved left ventricular function and regional wall motion and abolition of pacing-induced angina.
Thormann J; Schlepper M; Kramer W; Gottwik M; Kindler M
J Cardiovasc Pharmacol; 1983; 5(3):371-7. PubMed ID: 6191134
[No Abstract] [Full Text] [Related]
19. Effective and safe dose of intracoronary nicorandil in man.
Miwa K; Igawa A; Yamanishi K; Fujita M; Inouc H
Jpn Circ J; 1995 Nov; 59(11):736-44. PubMed ID: 8747763
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of nicorandil in congestive heart failure.
Galié N; Varani E; Maiello L; Boriani G; Boschi S; Binetti G; Magnani B
Am J Cardiol; 1990 Feb; 65(5):343-8. PubMed ID: 2137279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]